CODX
Co-Diagnostics, Inc. Common Stock
NasdaqCMUSDEQUITY
DELAYED
Last price
1.20
▲ 0.05 (4.35%)
MARKET · —
Price
Open
1.15
Prev close
1.15
Day high
1.23
Day low
1.13
Volume
292.30K
Market cap
—
P/E (TTM)
—
52W range
0.94 – 46.50
Trailing performance
Returnvs SPY
1W
-13.57%
-12.2%
1M
-45.25%
-49.0%
3M
-67.39%
-70.5%
6M
-50.61%
-61.7%
YTD
-76.13%
-88.4%
1Y
-85.70%
-105.7%
3Y
-96.72%
-170.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1.34
-10.58% from price
SMA 20
1.44
-16.03% from price
SMA 50
2.35
-48.57% from price
SMA 100
2.65
-54.69% from price
SMA 200
4.15
-70.82% from price
EMA 12
1.36
-11.59% from price
EMA 26
1.69
-29.07% from price
EMA 50
2.16
-44.56% from price
RSI (14)
30.3
Neutral
MACD (12,26,9)
-0.33
Hist 0.03
ATR (14)
0.15
12.78% of price
Realised vol 30D
122.8%
Annualised
Bollinger upper
1.82
20, 2σ
Bollinger lower
1.07
20, 2σ
50 / 200 cross
Death
2.35 vs 4.15
Trend bias
Below 200
-70.82%
Risk profile
Beta vs SPY
3.11
More volatile than market
Correlation to SPY
0.11
Largely independent
Realised vol 30D
122.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-97.1%
Peak to trough
Max drawdown 5Y
-99.7%
Peak to trough
ATR 14
0.15
12.78% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Co-Dx (CODX) Q2 2026 Earnings Call Transcript
Motley Fool · 2d ago
Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event
PR Newswire · 4d ago
Co-Diagnostics, Inc. Q2 2026 Earnings Call Summary
Moby · 8d ago
Co-Diagnostics Inc (CODX) (Q2 2026) Earnings Call Highlights: FDA Submission Milestone and ...
GuruFocus.com · 9d ago
Co-Diagnostics Reports Second Quarter 2026 Financial Results
PR Newswire · 9d ago
Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test
PR Newswire · 16d ago
OraSure Technologies Q2 Earnings Call Highlights
MarketBeat · 17d ago
Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast
PR Newswire · 23d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.